沿胸腔引流管接种的皮肤转移性肺腺癌:1例报告  

Skin metastasis along a pleural catheter with cutaneous metastatic lung adenocarcinoma:one case report

作　　者：张菡育 曹滇誉 王强 ZHANG Han-yu;CAO Dian-yu;WANG Qiang(Department of Dermatology,Zhongshan Hospital,Fudan University,Shanghai 200032,China)

机构地区：[1]复旦大学附属中山医院皮肤科,上海200032

出　　处：《复旦学报（医学版）》2024年第1期133-138,共6页Fudan University Journal of Medical Sciences

基　　金：上海市自然科学基金(23ZR1410800)。

摘　　要：本文报告复旦大学附属中山医院收治的1例沿胸腔引流管接种的皮肤转移性肺腺癌患者,男性,61岁,病程2周余。本例皮损泛发,表现为绿豆至小胡桃大小不等的紫红色结节,质硬、坚实,表面光滑,有浸润感,无破溃,无瘙痒、压痛。发疹前6周,患者无明显诱因下出现胸闷、胸部隐痛,痰液少、呈白色,在我院呼吸科确诊为左肺恶性肿瘤(低分化腺癌),cT1cN3M1cⅣB期,累及胸膜、骨。基因检测结果显示:表皮生长因子受体(epidermal growth factorreceptor,EGFR)21外显子点突变L858r,酪氨酸激酶胰岛素受体基因Ros1阴性,间变性淋巴瘤激酶(anaplastic lymphoma kinase,ALK)阴性,体力状况评分(physical status score,PS)为0分。给予达克替尼45 mg,口服,每日1次,联合伊班膦酸保骨治疗。由于患者病情改善不明显,皮肤结节增多,腹部B超提示肝脏多发转移灶,改用盐酸埃克替尼片(凯美纳),每日3次,每次125 mg,联合克唑替尼胶囊(赛可瑞),每日2次,每次200 mg。患者出院后家属代为复诊1次,之后失访。There was a 61-year-old male patient with cutaneous metastatic lung adenocarcinoma inoculated along a thoracic drainage tube treated in Zhongshan Hospital,Fudan University.The duration of disease was over 2 weeks.The skin lesions were extensive and appeared as purplish red nodules ranging in size from mung bean to small walnut.The nodules were tough and solid,smooth in surface,with infiltration while without ulceration,pruritus or tenderness.The patient developed chest tightness and pain without obvious causes,dull pain in nature and less white sputum 6 weeks before the eruption,and then was diagnosed as malignant tumors of the left lung(poorly differentiated adenocarcinoma),cT1cN3M1c stageⅣB(pleura,bone).Gene tests showed that epidermal growth factor receptor(EGFR)21 exon point mutation L858r,Ros1(-),anaplastic lymphoma kinase(ALK)(-),and physical status score(PS)of 0.The treatment was Dactinib 45mg once each day,supplemented the bone preservation therapy by ibandronic acid.As the patient's condition did not significantly improve and skin nodules increased,also the abdominal B-ultrasound examination showed that multiple metastases in liver,the treatment was changed to Ectinib hydrochloride tablets(Kemena)of 125 mg 3 times a day,combined with Crizotinib capsules(Secor)of 200 mg twice a day.Unfortunately,the patient has now been lost to follow-up.

关 键 词：肺腺癌 转移性 基因突变 皮肤 

分 类 号：R751[医药卫生—皮肤病学与性病学] R734.2[医药卫生—临床医学]